LLMpediaThe first transparent, open encyclopedia generated by LLMs

Serratia marcescens

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 51 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted51
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Serratia marcescens
Serratia marcescens
de:Benutzer:Brudersohn · CC BY-SA 3.0 · source
NameSerratia marcescens
DomainBacteria
PhylumProteobacteria
ClassisGammaproteobacteria
OrdoEnterobacterales
FamiliaEnterobacteriaceae
GenusSerratia
SpeciesS. marcescens

Serratia marcescens is a Gram-negative, facultatively anaerobic bacterium within the family Enterobacteriaceae known for producing red-orange prodigiosin pigment. It occupies diverse environmental niches, acts as an opportunistic pathogen in healthcare settings, and has been studied across microbiology, infectious disease, and public health contexts. Research and outbreaks have involved multiple institutions and public health agencies worldwide.

Taxonomy and Description

S. marcescens belongs to the genus Serratia within Enterobacterales and the class Gammaproteobacteria; it was historically classified using phenotypic schemes aligned with methods from Bergey's Manual traditions and later revised through molecular phylogenetics employing 16S rRNA and multilocus sequence analysis used by laboratories like those at the Centers for Disease Control and Prevention, National Institutes of Health, and university microbiology departments such as Harvard University and Johns Hopkins University. Diagnostic laboratories reference biochemical profiling panels produced by companies like Beckman Coulter and bioMérieux and use taxonomy standards from organizations such as the International Committee on Systematics of Prokaryotes.

History and Discovery

Descriptions of red-pigmented bacteria date to historical observations by naturalists and physicians in early modern Europe; formal isolation and naming occurred in the 19th century amid microbiological advances linked to researchers influenced by figures like Louis Pasteur and Robert Koch. Nomenclatural changes and clinical characterization paralleled developments at institutions including Imperial College London and national health laboratories, while notable hospital-associated investigations involved centers such as Mayo Clinic and the London School of Hygiene & Tropical Medicine.

Morphology and Physiology

Cells are rod-shaped, motile via peritrichous flagella, and measure typically 0.5–0.8 µm × 0.9–2.0 µm; colonies on nutrient agar can be mucoid or dry depending on capsule expression, a trait characterized in studies at University of Oxford and University of Cambridge. It grows across a range of temperatures and salinities, exhibits facultative anaerobiosis akin to other members of Enterobacterales, and metabolizes diverse substrates identified using methods standardized by organizations like the Clinical and Laboratory Standards Institute and analytical platforms from Shimadzu and Agilent Technologies.

Pigmentation and Biochemistry

The characteristic red pigment prodigiosin is a tripyrrole secondary metabolite biosynthesized via a gene cluster first mapped through genetic techniques popularized at institutions such as Massachusetts Institute of Technology and Stanford University. Prodigiosin biosynthesis intersects with global regulatory networks including quorum sensing elements analogous to systems studied in Pseudomonas aeruginosa and Vibrio cholerae; biochemical analyses employ chromatography equipment from Waters Corporation and Thermo Fisher Scientific. The organism also produces extracellular enzymes like proteases and lipases studied in industrial microbiology contexts at companies and labs such as DuPont and BASF.

Ecology and Habitat

S. marcescens is found in soil, water, plant surfaces, and damp indoor environments, with environmental surveys conducted by agencies such as the Environmental Protection Agency and academic groups at University of California, Berkeley and University of Tokyo. It colonizes plumbing, sinks, and moist medical devices—sites implicated in outbreak investigations by healthcare regulatory bodies including the World Health Organization and national public health institutes like Public Health England. Environmental persistence and biofilm formation draw parallels with organisms studied in ecology programs at institutions like Woods Hole Oceanographic Institution.

Pathogenicity and Clinical Significance

As an opportunistic pathogen, S. marcescens causes urinary tract infections, respiratory infections, wound infections, bloodstream infections, and device-associated infections; case series and guidelines have been published by clinical centers such as Cleveland Clinic and societies including the Infectious Diseases Society of America. Virulence factors include proteases, siderophores, and adherence determinants characterized in work connected to laboratories at Yale University and Columbia University. Antimicrobial resistance, including extended-spectrum beta-lactamases and carbapenemases, has been documented in surveillance programs run by organizations like the European Centre for Disease Prevention and Control and CDC; hospital outbreak reports have involved tertiary centers such as Mount Sinai Hospital and national reference labs in Germany and Japan.

Prevention, Control, and Treatment

Prevention emphasizes infection control measures practiced in hospitals and long-term care facilities guided by protocols from World Health Organization, CDC, and national health services like NHS England; these measures include hand hygiene standards promoted by WHO campaigns and equipment sterilization standards informed by bodies such as Association for the Advancement of Medical Instrumentation. Control of environmental reservoirs involves engineering and facility management informed by agencies including the U.S. Environmental Protection Agency and consultancies linked to Johnson Controls. Antimicrobial therapy is selected based on susceptibility testing per Clinical and Laboratory Standards Institute or European Committee on Antimicrobial Susceptibility Testing guidelines; treatment decisions often reference clinical practice guidelines from organizations like the Infectious Diseases Society of America and hospital antimicrobial stewardship programs at centers such as Stanford Health Care and Mayo Clinic.

Category:Enterobacteriaceae